» Articles » PMID: 31481566

Risk Factors for Bacteremia in Patients with Rheumatoid Arthritis and Incidence Compared with the General Population: Protocol for a Danish Nationwide Observational Cohort Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Sep 5
PMID 31481566
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: bacteremia (SAB) is an invasive infection with high mortality and morbidity. Rheumatoid arthritis (RA) is associated with increased risk of infections due to the disease per se and the use of antirheumatic treatments. Few minor studies have previously investigated risk of SAB in patients with RA and indicated increased risk compared with the general population. This nationwide observational study aims to investigate incidence of and risk factors for SAB in adult patients with RA compared with the general population. The effect of disease characteristics (eg, joint erosions, disease duration and activity), different antirheumatic treatments and smoking on SAB risk will be evaluated.

Methods And Analysis: All adults (>18 years of age) alive and living in Denmark in 1996-2017 will be identified in The Danish Civil Registration System. Incident patients with RA are identified in the Danish National Patient Registry (DNPR) and the nationwide rheumatology registry, DANBIO, in which information on, for example, antirheumatic treatments, disease characteristics and smoking is collected prospectively in routine care. Information on comorbidities, invasive procedures and prescribed drugs are identified in the DNPR and in The Register of Medicinal Product Statistics. Socioeconomic status is evaluated in national registers on income and education. Incident cases of first-time SAB are identified in The Danish National SAB Database. All registers are linked on an individual level by unique civil registration numbers. Incidence rates and incidence rate ratios will be analysed using Poisson regression models and the impact of possible risk factors will be evaluated.

Ethics And Dissemination: All data will be handled in accordance with the General Data Protection Regulation (EU) 2016/679. No ethical approval is necessary in Denmark when handling registry data only. The results will be presented in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology initiative in international peer-reviewed journals and at medical conferences.

Trial Registration Number: NCT03908086.

Citing Articles

At Early Rheumatoid Arthritis Stage, the Infectious Spectrum Is Driven by Non-Familial Factors and Anti-CCP Immunization.

Arleevskaya M, Novikov A, Valeeva A, Korovina M, Serdiuk I, Popov V J Clin Med. 2024; 13(10).

PMID: 38792338 PMC: 11122272. DOI: 10.3390/jcm13102796.


Antirheumatic treatment, disease activity and risk of bacteraemia in rheumatoid arthritis: a nationwide nested case-control study.

Dieperink S, Mehnert F, Norgaard M, Oestergaard L, Benfield T, Petersen A RMD Open. 2022; 8(2).

PMID: 36517186 PMC: 9756197. DOI: 10.1136/rmdopen-2022-002636.


Editorial: The interplay between the oral Microbiota and rheumatoid arthritis.

Manoil D, Bostanci N, Finckh A Front Oral Health. 2022; 3:1055482.

PMID: 36424996 PMC: 9679626. DOI: 10.3389/froh.2022.1055482.


Outer membrane vesicles of the oral pathogen promote aggregation and phagocytosis of .

du Teil Espina M, Haider Rubio A, Fu Y, Lopez-Alvarez M, Gabarrini G, van Dijl J Front Oral Health. 2022; 3:948524.

PMID: 35937774 PMC: 9354530. DOI: 10.3389/froh.2022.948524.

References
1.
Doran M, Crowson C, Pond G, OFallon W, Gabriel S . Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002; 46(9):2287-93. DOI: 10.1002/art.10524. View

2.
Bassetti S, Battegay M . Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection. 2004; 32(3):163-9. DOI: 10.1007/s15010-004-3106-0. View

3.
Wertheim H, Vos M, Ott A, van Belkum A, Voss A, Kluytmans J . Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004; 364(9435):703-5. DOI: 10.1016/S0140-6736(04)16897-9. View

4.
Jacobsson G, Dashti S, Wahlberg T, Andersson R . The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis. 2007; 39(1):6-13. DOI: 10.1080/00365540600810026. View

5.
Benfield T, Espersen F, Frimodt-Moller N, Jensen A, Larsen A, Pallesen L . Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect. 2007; 13(3):257-63. DOI: 10.1111/j.1469-0691.2006.01589.x. View